Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later.

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.

In a nutshell A common desert plant called Artemisia herba-alba contains compounds that can effectively kill colorectal ...

That will affect your treatment options and what you can expect -- or as doctors say, your prognosis. Both colon and rectal cancer affect the large intestine, which is the lowest part of the ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

Researchers investigated the factors associated with treatment delay in patients with early-onset colorectal cancers.

Scientists endow a naturally growing plant with therapeutic properties that can effectively fight colorectal cancer.

Genetic testing and at-home screenings for colon, prostate and cervical cancer give workers and their families access to ...

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...